Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | BIIB | ROIV | ||
| Company | Alnylam Pharmaceuticals | Biogen Inc | Roivant Sciences Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 205.46 | 207.51 | 34.28 | ||
| High | 207.99 | 208.05 | 34.50 | ||
| Low | 200.11 | 202.57 | 33.54 | ||
| Last | 205.52 | 202.95 | 33.91 | ||
| Change | +0.04 | -4.98 | -0.61 | ||
| Percent Change | +0.02% | -2.40% | -1.77% | ||
| Volume | 4,477,500 | 1,062,200 | 5,397,000 | ||
| 20-Day Average Volume | 2,162,480 | 1,470,095 | 4,651,715 | ||
| Previous | 205.48 | 207.93 | 34.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 279.24 | 202.76 | 34.86 | ||
| 20-Day Raw Stochastic | 4.23% | 51.97% | 25.90% | ||
| 20-Day Relative Strength | 27.40 | 50.84 | 52.24 | ||
| Weighted Alpha | -53.88 | +47.74 | +170.37 | ||
| Today's Opinion | 100% Sell | 96% Buy | 80% Buy | ||
| Yesterday's Opinion | 100% Sell | 96% Buy | 80% Buy | ||
| Last Month's Opinion | 72% Sell | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -24.38% since 07/24/26 | +0.38% since 07/24/26 | -3.14% since 07/24/26 | ||
| Low | 197.81 on 07/30/26 | 199.40 on 07/28/26 | 32.83 on 07/29/26 | ||
| High | 290.60 on 07/29/26 | 218.59 on 07/29/26 | 35.58 on 07/27/26 | ||
| 1-Month | |||||
| %Chg | -31.73% since 06/30/26 | -6.07% since 06/30/26 | -4.18% since 06/30/26 | ||
| Low | 197.81 on 07/30/26 | 186.02 on 07/15/26 | 32.83 on 07/29/26 | ||
| High | 380.00 on 07/09/26 | 219.01 on 07/02/26 | 37.00 on 07/10/26 | ||
| 3-Month | |||||
| %Chg | -33.59% since 04/30/26 | +7.22% since 04/30/26 | +18.86% since 04/30/26 | ||
| Low | 197.81 on 07/30/26 | 184.90 on 06/02/26 | 27.52 on 05/04/26 | ||
| High | 380.00 on 07/09/26 | 219.72 on 06/29/26 | 37.00 on 07/10/26 | ||
| 6-Month | |||||
| %Chg | -39.21% since 01/30/26 | +12.82% since 01/30/26 | +56.85% since 01/30/26 | ||
| Low | 197.81 on 07/30/26 | 168.64 on 04/06/26 | 20.98 on 02/02/26 | ||
| High | 380.00 on 07/09/26 | 219.72 on 06/29/26 | 37.00 on 07/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 27,439,592 | 29,986,670 | 24,390,448 | ||
| Shares Outstanding, K | 133,513 | 147,754 | 719,270 | ||
| Annual Sales, $M | 3,713,940,000 | 9,890,600,000 | 8,260,000 | ||
| Annual Net Income, $M | 313,750,000 | 1,292,900,000 | -299,770,000 | ||
| Last Qtr Sales, $M | 1,167,180,000 | 2,477,800,000 | 2,520,000 | ||
| Last Qtr Income, $M | 205,990,000 | 319,500,000 | 302,990,000 | ||
| 60-Month Beta | 0.27 | 0.16 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.84 on 07/30/26 | 3.60 on 07/29/26 | -0.36 on 05/20/26 | ||
| Latest Earnings Date | 10/29/26 | 10/29/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.19 | 14.88 | 0.00 | ||